Home » Topics » BioWorld Science

BioWorld Science
RSS

CTT-1403 enters phase I development for metastatic castration-resistant prostate cancer

April 17, 2019

Otsuka Pharmaceutical initiates two phase III studies of OPA-15406 ointment

April 17, 2019

Positive results presented from phase II/III TAZPOWER study of elamipretide

April 17, 2019

Entasis Therapeutics identifies novel series of PBP3 inhibitors for P. aeruginosa infections

April 17, 2019

Phase I/IIa trial of antibody-inducing peptide FPP-003 begins in Australia

April 17, 2019

RTD-1 shows promising preclinical results in mouse model of cystic fibrosis

April 17, 2019

Safety and immunogenicity of ChAdOx1 Chik vaccine in healthy adult volunteers

April 17, 2019

Discovery and characterization of a novel BCL6 inhibitor, OICR-10268

April 17, 2019

Preclinical characterization of novel anti-VISTA antibody for the treatment of cancer

April 17, 2019

BP-1003 shows promising activity in PDAC PDX models

April 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...